Accepted
at 2:36 a.m. Sep, 04, 2025
by
yelbardisi
Author:
yelbardisi
Co-authors:
andrewmathias8
Type of change:
Other
Rationale for change
having systemic outside the cloze gives away the answer
Before
After
Text
Text
Text
Text
Extra
Canakinumab is an IL-1 inhibitor
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy
Empty field
Sketchy 2




Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize



Review IL-1



Review IL-1
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Rheumatologic Diseases : Systemic Juvenile Idiopathic Arthritis
OME
Additional Resources
Empty field
One by one
Empty field
